41602-50-0
41602-50-0 structure
- Name: Ethyl 2-(2-chloroacetamido)acetate
- Chemical Name: ethyl 2-[(2-chloroacetyl)amino]acetate
- CAS Number: 41602-50-0
- Molecular Formula: C6H10ClNO3
- Molecular Weight: 179.60100
- Catalog: Biochemical Amino acids and their derivatives Glycine derivatives
- Create Date: 2018-09-14 13:26:59
- Modify Date: 2024-01-10 16:04:16
-
Ethyl 2-(2-chloroacetamido)acetate is a Glycine (HY-Y0966) derivative[1].
| Name | ethyl 2-[(2-chloroacetyl)amino]acetate |
|---|---|
| Synonyms |
ethyl N-(2-chloroacetyl)-glycinate
MFCD00216646 N-(Chloroacetyl)glycine ethyl ester ethyl 2-(2-chloroacetylamino)acetate N-(ethoxycarbonylmethyl)-2-chloroacetamide ethyl 2-(2-chloroacetamido)acetate chloroacetyl glycine ethyl ester |
| Description | Ethyl 2-(2-chloroacetamido)acetate is a Glycine (HY-Y0966) derivative[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
| References |
| Density | 1.21g/cm3 |
|---|---|
| Boiling Point | 296.4ºC at 760mmHg |
| Melting Point | 62-65ºC(lit.) |
| Molecular Formula | C6H10ClNO3 |
| Molecular Weight | 179.60100 |
| Flash Point | 133.1ºC |
| Exact Mass | 179.03500 |
| PSA | 55.40000 |
| LogP | 0.29540 |
| Index of Refraction | 1.452 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~68%
41602-50-0 |
| Literature: Pautus, Stephane; Sehr, Peter; Lewis, Joe; Fortune, Antoine; Wolkerstorfer, Andrea; Szolar, Oliver; Guilligay, Delphine; Lunardi, Thomas; Decout, Jean-Luc; Cusack, Stephen Journal of Medicinal Chemistry, 2013 , vol. 56, # 21 p. 8915 - 8930 |
|
~73%
41602-50-0 |
| Literature: Goodson, John J.; Wharton, Clifford J.; Wrigglesworth, Roger Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980 , p. 2721 - 2727 |
|
~%
41602-50-0 |
| Literature: Looker,J.H.; Carpenter,J.W. Canadian Journal of Chemistry, 1967 , vol. 45, p. 1727 - 1734 |
|
~%
41602-50-0 |
| Literature: Looker,J.H.; Carpenter,J.W. Canadian Journal of Chemistry, 1967 , vol. 45, p. 1727 - 1734 |
|
~%
41602-50-0 |
| Literature: Diels; Heintzel Chemische Berichte, 1905 , vol. 38, p. 304 |
|
~%
41602-50-0 |
| Literature: Diels; Heintzel Chemische Berichte, 1905 , vol. 38, p. 304 |
